Press release year list 2021 2020 2019 2018 2017 2016 2015
September 16, 2021
Aptinyx Secures $50 Million Growth Capital Credit Facility from K2 HealthVentures
Download PDF format download (opens in new window)
August 31, 2021
Aptinyx to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
Download PDF format download (opens in new window)
August 10, 2021
Aptinyx Reports Second Quarter 2021 Financial Results and Business Highlights
Download PDF format download (opens in new window)
August 03, 2021
Aptinyx to Participate in 2021 Wedbush PacGrow Healthcare Virtual Conference
Download PDF format download (opens in new window)
July 26, 2021
Aptinyx to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021
Download PDF format download (opens in new window)
July 12, 2021
Aptinyx to Participate in William Blair Biotech Focus Conference 2021
Download PDF format download (opens in new window)
July 06, 2021
Aptinyx to Participate in Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
Download PDF format download (opens in new window)
June 17, 2021
Aptinyx to Participate in Upcoming Investor Conferences
Download PDF format download (opens in new window)
June 15, 2021
Aptinyx Provides Update on NYX-783 Development Program for the Treatment of Post-Traumatic Stress Disorder
Download PDF format download (opens in new window)
May 13, 2021
Aptinyx Reports First Quarter 2021 Financial Results and Highlights
Download PDF format download (opens in new window)
May 10, 2021
Aptinyx Appoints Joan W. Miller, M.D. to Board of Directors
Download PDF format download (opens in new window)
April 29, 2021
Aptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
Download PDF format download (opens in new window)
April 29, 2021
Aptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting
Download PDF format download (opens in new window)
April 27, 2021
Aptinyx to Participate in Upcoming Conferences
Download PDF format download (opens in new window)
April 06, 2021
Aptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson’s Disease Dementia and Dementia with Lewy Bodies
Download PDF format download (opens in new window)
March 24, 2021
Aptinyx Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Download PDF format download (opens in new window)
March 02, 2021
Aptinyx to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 24, 2021
Download PDF format download (opens in new window)
February 22, 2021
Aptinyx to Participate in Upcoming Investor Conferences
Download PDF format download (opens in new window)
February 11, 2021
Aptinyx to Participate at 10th Annual SVB Leerink Global Healthcare Conference
Download PDF format download (opens in new window)
January 19, 2021
Aptinyx Announces Publication of Review Article Highlighting Preclinical Data in Medicine in Drug Discovery Demonstrating the Potential of NYX-2925 to Treat Chronic, Centralized Pain Conditions
Download PDF format download (opens in new window)
January 05, 2021
Aptinyx to Participate in H.C. Wainwright BioConnect 2021 Conference
Download PDF format download (opens in new window)
January 04, 2021
Aptinyx Announces Recommencement of Phase 2 Study of NYX-2925 in Patients With Painful Diabetic Peripheral Neuropathy
Download PDF format download (opens in new window)